insights_auto
Why is MNKD down 3.80%?
Dive Deeperchevron_right
MNKD:NASDAQ
MannKind Corp
$3.80
arrow_downward
-3.80%(-0.15) 1D
$3.81
arrow_upward
+0.26% (+0.0100)bedtimeAfter hours
Closed: Oct 2, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MNKD...
Open
$4.01
High
$4.01
Low
$3.70
Mkt. cap
1.22B
Avg. vol.
4.32M
Volume
4.61M
52-wk high
$6.51
52-wk low
$2.23
EPS
-$0.14
Beta
1.09
Shares outstanding
321.54M
No. of employees
592
Open
$4.01
High
$4.01
Low
$3.70
Mkt. cap
1.22B
Avg. vol.
4.32M
Volume
4.61M
52-wk high
$6.51
52-wk low
$2.23
EPS
-$0.14
Beta
1.09
Shares outstanding
321.54M
No. of employees
592
News stories
From web sources and news partners
Simply Wall Street
·
9 minutes ago
What You Can Learn From ON Semiconductor Holders Up 72%
Business Insider
·
2 hours ago
The NYSE's Most Famous Floor Trader Says AI Can't Take His Job
Yahoo Finance
·
35 minutes ago
Nasdaq Hits Fresh Ground on Chip and Software Strength as Dow, Small Caps Lag for the Week
Profile
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann. Wikipedia
About MannKind Corp
CEOMichael Castagna
Employees592
FoundedFeb 1991
HeadquartersDanbury, Connecticut, United States
SectorBiotechnology
Websitemannkindcorp.com